113 related articles for article (PubMed ID: 37337706)
1. Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity.
Ferraro G; Sanfilippo V; Chiaverini L; Satriano C; Marzo T; Merlino A; La Mendola D
Dalton Trans; 2023 Jul; 52(26):9058-9067. PubMed ID: 37337706
[TBL] [Abstract][Full Text] [Related]
2. Pd-Based Hybrid Nanoparticles As Multimodal Theranostic Nanomedicine.
Bellissima A; Cucci LM; Sanfilippo V; De Bonis A; Fiorenza R; Scirè S; Marzo T; Severi M; La Mendola D; Notarstefano V; Giorgini E; Satriano C
ACS Appl Bio Mater; 2023 Feb; 6(2):483-493. PubMed ID: 36651801
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents.
Custódio JB; Cardoso CM; Santos MS; Almeida LM; Vicente JA; Fernandes MA
Toxicology; 2009 May; 259(1-2):18-24. PubMed ID: 19428939
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.
Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P
Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033
[TBL] [Abstract][Full Text] [Related]
5. Different patterns of apoptosis in response to cisplatin in B50 neuroblastoma rat cells.
Santin G; Piccolini VM; Veneroni P; Barni S; Bernocchi G; Bottone MG
Histol Histopathol; 2011 Jul; 26(7):831-42. PubMed ID: 21630213
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.
Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801
[TBL] [Abstract][Full Text] [Related]
7. Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment.
Muscella A; Urso L; Calabriso N; Ciccarese A; Migoni D; Fanizzi FP; Di Jeso B; Storelli C; Marsigliante S
Biochem Pharmacol; 2005 Dec; 71(1-2):50-60. PubMed ID: 16297374
[TBL] [Abstract][Full Text] [Related]
8. Mechanical stress promotes cisplatin-induced hepatocellular carcinoma cell death.
Ziko L; Riad S; Amer M; Zdero R; Bougherara H; Amleh A
Biomed Res Int; 2015; 2015():430569. PubMed ID: 25685789
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment.
Bottone MG; Soldani C; Veneroni P; Avella D; Pisu M; Bernocchi G
Cell Prolif; 2008 Jun; 41(3):506-20. PubMed ID: 18397337
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric analysis of the effectiveness of cisplatin on cutaneous squamous carcinoma cells using two different types of adjuvants.
Gil S; Solano E; Martínez-Trucharte F; Martínez-Esaín J; Pérez-Berná AJ; Conesa JJ; Kamma-Lorger C; Alsina M; Sabés M
PLoS One; 2020; 15(3):e0230022. PubMed ID: 32143211
[TBL] [Abstract][Full Text] [Related]
12. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.
Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M
Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O'-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells.
Grimaldi M; Bo VD; Ferrari B; Roda E; De Luca F; Veneroni P; Barni S; Verri M; De Pascali SA; Fanizzi FP; Bernocchi G; Bottone MG
Toxicol Appl Pharmacol; 2019 Feb; 364():1-11. PubMed ID: 30529627
[TBL] [Abstract][Full Text] [Related]
14. Coordination Environment of Cu(II) Ions Bound to N-Terminal Peptide Fragments of Angiogenin Protein.
Magrì A; Munzone A; Peana M; Medici S; Zoroddu MA; Hansson O; Satriano C; Rizzarelli E; La Mendola D
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490533
[TBL] [Abstract][Full Text] [Related]
15. Use of C. elegans as a 3R-compliant in vivo model for the chemoprevention of cisplatin-induced neurotoxicity.
Wellenberg A; Weides L; Kurzke J; Hennecke T; Bornhorst J; Crone B; Karst U; Brinkmann V; Fritz G; Honnen S
Exp Neurol; 2021 Jul; 341():113705. PubMed ID: 33753139
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z
Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962
[TBL] [Abstract][Full Text] [Related]
17. Beyond Single-Cell Analysis of Metallodrugs by ICP-MS: Targeting Cellular Substructures.
Galé A; Hofmann L; Lüdi N; Hungerbühler MN; Kempf C; Heverhagen JT; von Tengg-Kobligk H; Broekmann P; Ruprecht N
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502377
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Cisplatin Efficacy on HepG2 and E. coli Cells under Acidic Conditions.
Babaei F; Ebrahimi Shahmabadi H; Rajabi MR; Haddad Kashani H; Izadpanah F
Asian Pac J Cancer Prev; 2019 Mar; 20(3):723-726. PubMed ID: 30909670
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells.
Marzo T; Ferraro G; Cucci LM; Pratesi A; Hansson Ö; Satriano C; Merlino A; La Mendola D
J Inorg Biochem; 2022 Jan; 226():111657. PubMed ID: 34784565
[TBL] [Abstract][Full Text] [Related]
20. Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines.
Rimoldi I; Coccè V; Facchetti G; Alessandri G; Brini AT; Sisto F; Parati E; Cavicchini L; Lucchini G; Petrella F; Ciusani E; Pessina A
Biomed Pharmacother; 2018 Dec; 108():111-118. PubMed ID: 30218855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
